NEW YORK – Oncimmune Holdings on Tuesday announced a contract with Roche Pharmaceuticals to utilize its infectious disease panel in a COVID-19 pneumonia drug trial.
NEW YORK – Oncimmune Holdings on Tuesday announced a contract with Roche Pharmaceuticals to utilize its infectious disease panel in a COVID-19 pneumonia drug trial.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.